About 5,343 results

ALLMedicine™ Coronary Heart Disease Center

Research & Reviews  1,681 results

Frailty and cardiovascular outcomes in the National Health and Aging Trends Study.
European Heart Journal; Damluji AA, Chung SE et. al.

Jul 30th, 2021 - Physical frailty is a commonly encountered geriatric syndrome among older adults without coronary heart disease (CHD). The impact of frailty on the incidence of long-term cardiovascular outcomes is not known. We aimed to evaluate the long-term ass...

Potential for optimizing management of obesity in the secondary prevention of coronary ...
European Heart Journal. Quality of Care & Clinical Outcomes; De Bacquer D, Jennings CS et. al.

Jul 28th, 2021 - Prevention guidelines have identified the management of obese patients as an important priority to reduce the burden of incident and recurrent cardiovascular disease. Still, studies have demonstrated that over 80% of patients with coronary heart d...

Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and...
BMC Cardiovascular Disorders; Oye-Somefun A, Kuk JL et. al.

Jul 28th, 2021 - We examined the relationship between ratios of select biomarkers of kidney and liver function on all-cause and coronary heart disease (CHD) mortality, both in isolation, and in combination with metabolic syndrome (MetS), among adults (20 + years, ...

Poor adherence to lifestyle recommendations in patients with coronary heart disease: re...
European Journal of Preventive Cardiology; De Bacquer D, Astin F et. al.

Jul 23rd, 2021 - Despite the high use of cardioprotective medications, the risk factor control in patients with coronary heart disease (CHD) is still inadequate. Guidelines identify healthy lifestyles as equally important in secondary prevention as pharmacotherapy...

Changes in the Biomarkers of Oxidative/Nitrosative Stress and Endothelial Dysfunction A...
Current Issues in Molecular Biology; Ferlazzo N, Currò M et. al.

Jul 22nd, 2021 - Patients with cardiovascular disease (CVD) and periodontitis (PT) show shared risk factors as result of the altered molecular mechanisms associated with pathological conditions. The aim of our study was to evaluate if the plasma biomarkers associa...

see more →

Guidelines  1 results

Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preve...
Annals of Internal Medicine;

Oct 7th, 2009 - New recommendation from the U.S. Preventive Services Task Force (USPSTF) on the use of nontraditional, or novel, risk factors in assessing the coronary heart disease (CHD) risk of asymptomatic persons. Systematic reviews were conducted of literatu...

see more →

Drugs  84 results see all →

Clinicaltrials.gov  114 results

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease

Mar 23rd, 2020 - A Randomized, Double-blind, Placebo-controlled, Parallel-designed Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Participants with Stable Coronary Heart Disease.

Exercise and Pharmacotherapy for Anxiety in Cardiac Patients

Mar 12th, 2020 - Coronary heart disease (CHD) is the leading cause of death in the United States; more than 600,000 Americans suffer a fatal cardiac event each year. Traditional CHD risk factors such as high blood pressure, smoking, and elevated cholesterol do not...

University of North Carolina Alumni Heart Study

Mar 4th, 2020 - BACKGROUND: Prevention of coronary heart disease (CHD) will be enhanced by controlling hypertension, reducing blood cholesterol, maintaining normal weight, increasing physical activity, reducing smoking, and having a healthy diet. Understanding ho...

A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381

Jan 3rd, 2020 - This 2 arm study will assess the long term safety and efficacy of RO4607381 in patients with coronary heart disease or a coronary heart disease (CHD) risk equivalent who have completed study NC19453. Patients eligible to participate in the extensi...

Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease

Nov 1st, 2019 - Patients with chronic, stable angina with documented coronary artery disease are eligible for the study.

see more →

News  254 results

ADAPTABLE: Low-Dose Aspirin as Good as High-Dose in CHD?

May 15th, 2021 - There was no significant difference in cardiovascular events or major bleeding between patients with established coronary heart disease (CHD) assigned to a daily aspirin dose of 81 mg and those receiving a dose of 325 mg in the 15,000-patient ADAP...

NHS England to Introduce 3D Heart Scans for Quicker Diagnosis of CAD

May 5th, 2021 - NHS England is to introduce a pioneering technology called HeartFlow for quicker diagnosis and treatment of suspected heart disease. HeartFlow transforms a regular cardiac computerised tomography (CT) scan into a three-dimensional (3D) image, enab...

Long Work Hours Tied to Double the Risk for Recurrent MI

Apr 5th, 2021 - Patients who work upward of 55 hours per week after a myocardial infarction (MI) may increase their risk of having a recurrence, a new study suggests. Over a 6-year period, investigators studied close to 1000 patients younger than 60 years who ret...

Diabetes Is Potent Predictor of Heart Disease in Women Under 65

Feb 2nd, 2021 - Women with diabetes aged between 45 and 65 years have a 10-fold increased risk of coronary heart disease (CHD) compared with those of similar age without diabetes, according to a new analysis of the US-based Women's Health Study. Identifying indiv...

Female Cardiac Advantage Essentially Lost After MI

Oct 7th, 2020 - Women are known to lag 5 to 10 years behind men in experiencing coronary heart disease (CHD), but new research suggests the gap narrows substantially following a myocardial infarction (MI). "Women lose a considerable portion, but not all, of their...

see more →

Patient Education  3 results see all →